Pain Relief and Safety Outcomes with Cervical 10 kHz Spinal Cord Stimulation: Systematic Literature Review and Meta-analysis.

Autor: Baranidharan G; Leeds Teaching Hospitals NHS Trust Leeds, Leeds, UK. g.baranidharan@nhs.net.; Faculty of Medicine and Health, School of Medicine, Leeds, UK. g.baranidharan@nhs.net., Bretherton B; Leeds Teaching Hospitals NHS Trust Leeds, Leeds, UK.; Faculty of Biomedical Sciences, School of Biological Sciences, Leeds, UK., Montgomery C; Leeds Teaching Hospitals NHS Trust Leeds, Leeds, UK., Titterington J; Leeds Teaching Hospitals NHS Trust Leeds, Leeds, UK., Crowther T; Leeds Teaching Hospitals NHS Trust Leeds, Leeds, UK., Vannabouathong C; Telos Partners LLC, San Diego, CA, USA., Inzana JA; Telos Partners LLC, San Diego, CA, USA., Rotte A; Nevro Corp, Redwood City, CA, USA. anand.rotte@nevro.com.
Jazyk: angličtina
Zdroj: Pain and therapy [Pain Ther] 2021 Dec; Vol. 10 (2), pp. 849-874. Date of Electronic Publication: 2021 May 25.
DOI: 10.1007/s40122-021-00269-6
Abstrakt: Background: Chronic pain in head, neck, shoulders and upper limbs is debilitating, and patients usually rely on pain medications or surgery to manage their symptoms. However, given the current opioid epidemic, non-pharmacological interventions that reduce pain, such as spinal cord stimulation (SCS), are needed. The purpose of this study was to review the evidence on paresthesia-free 10 kHz SCS therapy for neck and upper extremity pain.
Methods: Systematic literature search was performed for studies reporting outcomes for cervical 10 kHz SCS using date limits from May 2008 to November 2020. The study results were analyzed and described qualitatively. Additionally, when feasible, meta-analyses of the outcome data, with 95% confidence intervals (CIs), were conducted using both the fixed-effects (FE) and random-effects (RE) models.
Results: A total of 15 studies were eligible for inclusion. The proportion of patients who achieved ≥ 50% pain reduction was 83% (95% CI 77-89%) in both the FE and RE models. The proportion of patients who reduced/eliminated their opioid consumption was 39% (95% CI 31-46%) in the FE model and 39% (95% CI 31-48%) in the RE model. Pain or discomfort with the implant, lead migration, and infections were potential risks following cervical SCS. Explant rate was 0.1 (95% CI 0.0-0.2) events per 100 person-months, and no patients in the included studies experienced a neurological complication or paresthesia.
Conclusion: Findings suggest 10 kHz SCS is a promising, safe, minimally invasive alternative for managing chronic upper limb and neck pain.
(© 2021. The Author(s).)
Databáze: MEDLINE
Externí odkaz: